Malin Lindstedt Selected Research

4-phenylenediamine (p-phenylenediamine)

9/2019

Evaluation of in vitro testing strategies for hazard assessment of the skin sensitization potential of "real-life" mixtures: The case of henna-based hair-colouring products containing p-phenylenediamine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Malin Lindstedt Research Topics

Disease

14	Neoplasms (Cancer) 12/2024 - 09/2012
3	Rhinosinusitis 01/2023 - 01/2016
3	Hypersensitivity (Allergy) 07/2013 - 10/2010
2	Seasonal Allergic Rhinitis (Hay Fever) 01/2022 - 01/2011
2	Tonsillar Neoplasms 01/2022 - 01/2018
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 12/2021 - 06/2014
2	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 10/2019 - 02/2019
2	Allergic Contact Dermatitis 09/2019 - 04/2013
2	Immediate Hypersensitivity 02/2018 - 07/2014
2	Urinary Bladder Neoplasms (Bladder Cancer) 03/2015 - 09/2012
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2024
1	Melanoma (Melanoma, Malignant) 12/2024
1	Autoimmune Diseases (Autoimmune Disease) 03/2024
1	Squamous Cell Carcinoma of Head and Neck 01/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Allergic Rhinitis 01/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2018
1	Skin Diseases (Skin Disease) 04/2013
1	Noninfiltrating Intraductal Carcinoma (DCIS) 04/2005
1	Inflammation (Inflammations) 04/2005

Drug/Important Bio-Agent (IBA)

6	AntigensIBA 01/2023 - 06/2014
6	AllergensIBA 01/2022 - 04/2005
4	Proteins (Proteins, Gene)FDA Link 04/2023 - 02/2018
3	CytokinesIBA 03/2024 - 04/2005
2	Interleukin-2 (IL2)IBA 12/2024 - 03/2024
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2023 - 11/2022
2	AntibodiesIBA 11/2022 - 03/2015
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2021
2	Pattern Recognition ReceptorsIBA 12/2021 - 06/2014
1	KynurenineIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Immune Checkpoint ProteinsIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	Tryptophan (L-Tryptophan)FDA Link 01/2023
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2023
1	OvalbuminIBA 11/2022
1	Bispecific AntibodiesIBA 11/2022
1	InterferonsIBA 01/2022
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 12/2021
1	Chemokine ReceptorsIBA 12/2021
1	DNA (Deoxyribonucleic Acid)IBA 10/2019
1	4-phenylenediamine (p-phenylenediamine)FDA Link 09/2019
1	Tuberculin (PPD)IBA 09/2019
1	Cancer VaccinesIBA 01/2018
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2017
1	mitazalimabIBA 03/2015
1	C-Type Lectins (C-Type Lectin)IBA 06/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2014
1	Immunoglobulin E (IgE)IBA 07/2013
1	HaptensIBA 04/2013
1	Interleukin-10 (Interleukin 10)IBA 09/2012
1	Interleukin-6 (Interleukin 6)IBA 09/2012
1	Interleukin-12 (IL 12)IBA 09/2012
1	Monoclonal AntibodiesIBA 09/2012
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2011

Therapy/Procedure

8	Immunotherapy 05/2024 - 10/2010
5	Therapeutics 05/2024 - 01/2011
2	Intranasal Administration 01/2022 - 01/2016
1	Transplantation 01/2023